EUVIMEDEUVIMED entdecken
Open Access

Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK

Weihua Liu, Yu Zhao, Zhongfeng Liu, Guangji Zhang, Huantong Wu, Xin Zheng, Xihe Tang, Zhiguo Chen

Cellular Oncology · 2023

DOI: 10.1007/s13402-023-00842-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2023. Verfasst von Weihua Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Dis…. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Beijing Talents Foundation, Beijing Municipal Health Commission Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaHumansAnimalsMiceSimplexvirusLeukocytes, MononuclearGanciclovirThymidine Kinase

Stichwörter der Autor:innen

Bystander anti-tumor effectGD2-specific chimeric antigen receptor engineered NK cellsHigh-grade glioblastomaImmunotherapyInduced neural stem cells

Substanzen

GanciclovirThymidine Kinase

Autor:innen und Institutionen

  • Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Diseases, and Key Laboratory of Neurodegenerative Diseases, Ministry of E…
  • Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing, 100069, China.
  • Neurosurgery Center of Aeronautical General Hospital, Beijing, 100012, China.
  • Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing, 100069, China. chenzhiguo@gmail.com.
  • , Beijing, China. chenzhiguo@gmail.com.

Förderung

  • National Natural Science Foundation of China
  • Beijing Talents Foundation
  • Beijing Municipal Health Commission Fund

Zitieren

APA

Liu, W., Zhao, Y., Liu, Z., Zhang, G., Wu, H., Zheng, X., Tang, X., & Chen, Z. (2023). Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK. Cellular Oncology. https://doi.org/10.1007/s13402-023-00842-5

Vancouver

Liu W, Zhao Y, Liu Z, Zhang G, Wu H, Zheng X, et al. Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK. Cellular Oncology. 2023. doi:10.1007/s13402-023-00842-5

BibTeX
@article{Liu2023,
  author = {Liu, Weihua and Zhao, Yu and Liu, Zhongfeng and Zhang, Guangji and Wu, Huantong and Zheng, Xin and Tang, Xihe and Chen, Zhiguo},
  title = {Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK},
  journal = {Cellular Oncology},
  year = {2023},
  doi = {10.1007/s13402-023-00842-5}
}
Kostenlos starten →